Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis

Gastroenterology. 1998 Feb;114(2):311-8. doi: 10.1016/s0016-5085(98)70482-2.


Background & aims: Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that occasionally progresses to cirrhosis but usually has a benign course. The aim of this study was to investigate the role of the hemochromatosis mutation Cys282Tyr in development of the mild hepatic iron overload found in some patients with NASH and its association with hepatic damage in these patients.

Methods: Fifty-one patients with NASH were studied. The presence of the Cys282Tyr mutation was tested in all patients, and the data were analyzed with respect to the histological grade of steatosis, inflammation, Perls' staining, hepatic iron concentration (HIC), and serum iron indices.

Results: Thirty-one percent of patients with NASH were either homozygous or heterozygous for the Cys282Tyr mutation. This mutation was significantly associated with Perls' stain grade (P < 0.005), HIC (P < 0.005), and transferrin saturation percentage (P < 0.005) but not with serum ferritin levels. Linear regression analysis showed that increased hepatic iron (Perls' stain or HIC) had the greatest association with the severity of fibrosis (P < 0.0001).

Conclusions: The Cys282Tyr mutation is responsible for most of the mild iron overload found in NASH and thus has a significant association with hepatic damage in these patients. Heterozygosity for the hemochromatosis gene mutation therefore cannot always be considered benign.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chronic Disease
  • Cohort Studies
  • Fat Necrosis / complications*
  • Fat Necrosis / metabolism
  • Fat Necrosis / pathology
  • Fatty Liver / complications*
  • Fatty Liver / metabolism
  • Fatty Liver / pathology
  • Female
  • Genetic Markers
  • Hemochromatosis / genetics*
  • Hemochromatosis / pathology
  • Heterozygote
  • Homozygote
  • Humans
  • Liver Cirrhosis / genetics*
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology
  • Male
  • Middle Aged
  • Mutation*
  • Sex Factors


  • Genetic Markers